The effort to develop novel therapies for incremental survival gains overlooks a major opportunity. Simply ensuring patients can afford and access existing care through financial support could potentially yield equivalent or greater survival improvements, reframing the value and urgency of addressing financial toxicity.

A study revealed a paradox: patients with *moderate* financial toxicity had the highest out-of-pocket payments. Those with *severe* toxicity had the most "write-offs" or bad debt. This indicates the worst financial distress isn't just about what patients pay, but what they are unable to pay.

Rising premiums and deductibles are pushing people away from traditional insurance. This isn't an abandonment of healthcare, but a market response to a product that no longer provides adequate value, forcing a shift towards cash-pay and alternative models.

The US healthcare system rewards inefficiency, with multiple parties adding costs. Cash-pay systems bypass this, offering services and drugs at a lower net price by avoiding negotiations and markups inherent in the insurance-based model.

The surge in consumer-led testing and screening will likely increase short-term healthcare utilization as people follow up on results. The long-term savings from earlier disease detection and management will only materialize over time, creating a J-curve effect on costs.

A surprising driver of the burgeoning global obesity drug market, projected to hit $20 billion outside the U.S., is that it's almost entirely cash-pay. Consumers in countries like the UK are willing to spend hundreds of dollars per month out-of-pocket, demonstrating strong demand independent of traditional reimbursement systems.

The shift to high-deductible plans forced consumers to directly feel the financial burden of healthcare. This created a new willingness to pay out-of-pocket for disruptively priced, superior consumer health services, effectively establishing a viable direct-to-consumer (DTC) market that investors previously dismissed.

Healthcare prices have risen 2.5 times more than groceries, but consumers are less sensitive to these increases. Unlike the frequent, tangible cost of eggs, infrequent medical bills make people "numb" to rising prices, masking a major source of inflation that policy changes can suddenly make visible.

For individuals with a multi-million dollar net worth, forgoing expensive health insurance can be a rational financial choice. The substantial savings on premiums (e.g., $300-400k over a decade) can create a fund large enough to cover most medical costs out-of-pocket, effectively creating a self-insurance pool.